Evolus, Inc. (EOLS)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-05) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-04) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-03) · 99.1 | 8-K (2026-01-09) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-05) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-05) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-07) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-04) · 99.1 | 8-K (2025-01-21) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-07-31) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-07) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-07) · 99.1 | 8-K (2024-01-16) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-07) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Stockholders Equity (deficit) | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Basis of Presentation and Summary of Significant Accounting Policies | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Description of Business | ||
| Employee Benefit Plan | — |
|
| Fair Value Measurements | ||
| Goodwill and Intangible Assets | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Long-term Debt | — |
|
| Medytox Settlement Agreements | ||
| Medytox/allergan Settlement Agreements | — |
|
| Medytox/allergan Settlement Agreements and Daewoong Arrangement | ||
| Operating Leases | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment | — |
|
| Property, Plant and Equipment | ||
| Segment Reporting | ||
| Segment Reporting and Customer Concentration | — |
|
| Shareholders' Equity | — |
|
| Stock-based Compensation and Stockholders Equity | ||
| Stockholders' Equity | ||
| Subsequent Events | ||
| Term Loans | ||